Your search returned 4 results.

Results
	1.	Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress. [electronic resource] by Dawson, Lee A Porter, Roderick A Producer: 20140319 In: Future medicinal chemistry vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1. [electronic resource] by Rahman, Shahzad S Coulton, Steven Herdon, Hugh J Joiner, Graham F Jin, Jian Porter, Roderick A Producer: 20070529 In: Bioorganic & medicinal chemistry letters vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Acylglycinamides as inhibitors of glycine transporter type 1. [electronic resource] by Blunt, Richard Porter, Roderick Johns, Amanda Nash, David Puckey, Gemma Wyman, Paul Herdon, Hugh Teague, Simon Hadden, Victoria Fontana, Stefano Gordon, Laurie Producer: 20120118 In: Bioorganic & medicinal chemistry letters vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors. [electronic resource] by Menon, Malini Elliott, Richard Bowers, Leandra Balan, Nicolae Rafiq, Rumana Costa-Cabral, Sara Munkonge, Felix Trinidade, Ines Porter, Roderick Campbell, Andrew D Johnson, Emma R Esdar, Christina Buchstaller, Hans-Peter Leuthner, Birgitta Rohdich, Felix Schneider, Richard Sansom, Owen Wienke, Dirk Ashworth, Alan Lord, Christopher J Producer: 20200430 In: Scientific reports vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)